NASSIM H NABBOUT M.D. NPI 1528029147

NPI Information

  • NPI: 1528029147
  • Provider Name: NASSIM H NABBOUT, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3243 E MURDOCK ST
    SUITE 300
    WICHITA, KS
    ZIP 67208
  • Phone: (316) 262-4467

Map and Directions

Get Directions

NPI Details

Nassim H Nabbout, M.D. is a hematology and oncology internal medicine in Wichita, KS with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Nassim H Nabbout, M.D. NPI is 1528029147. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3243 E MURDOCK ST
SUITE 300
WICHITA, KS
ZIP 67208-052
Phone: (316) 262-4467
Fax: (316) 262-0706

The NPI 1528029147 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Magnesium level (HCPCS:83735)
  • Phosphate level (HCPCS:84100)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Uric acid level, blood (HCPCS:84550)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Total protein level, urine (HCPCS:84156)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml (HCPCS:Q9965)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Red blood count, automated test (HCPCS:85045)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)

The enumeration date for this NPI number is 3/31/2006 and was last updated on 7/21/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology0429749KANSASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11286700002OTHERKANSASDMERC REGION 1
212867010010OTHERKANSASDMERC REGION 1
31286700003OTHERKANSASDMERC REGION 1
41286700005OTHERKANSASDMERC REGION 1
51286700009OTHERKANSASDMERC REGION 1
61286700007OTHERKANSASDMERC REGION 1
71286700012OTHERKANSASDMERC REGION 1
81286700008OTHERKANSASDMERC REGION 1
9100427880AMEDICAIDKANSAS
101286700004OTHERKANSASDMERC REGION 1
111286700013OTHERKANSASDMERC REGION 1
121286700015OTHERKANSASDMERC REGION 1
131286700011OTHERKANSASDMERC REGION 1
141286700006OTHERKANSASDMERC REGION 1

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.